Amit Kulkarni, Ph.D.
Head of Health Economic Modeling and Decision Sciences
Princeton, New Jersey, United States
Professional Overview
Amit Kulkarni, Ph.D., is a seasoned leader in the pharmaceutical industry, with extensive expertise in health economic modeling, decision sciences, and real-world evidence generation. In his current role as the Head of Health Economic Modeling and Decision Sciences at Otsuka Pharmaceutical Companies (U.S.), he is responsible for driving strategic initiatives that leverage advanced analytics and data-driven insights to optimize decision-making and improve patient outcomes.
Experience Summary
Current Role
As the Head of Health Economic Modeling and Decision Sciences at Otsuka Pharmaceutical Companies (U.S.), Dr. Kulkarni oversees a team of health economists, epidemiologists, and decision scientists. He is responsible for developing innovative approaches to health economic modeling, conducting cost-effectiveness analyses, and generating real-world evidence to support the company's market access strategies. Under his leadership, the department has made significant contributions to the successful commercialization of Otsuka's pharmaceutical products, ensuring their value is accurately captured and communicated to key stakeholders.
Career Progression
Prior to joining Otsuka, Dr. Kulkarni held various leadership positions in the pharmaceutical and healthcare industries, including Director of the Center for Observational and Real World Evidence at Merck, Sr. Manager of Corporate Market Access and Pricing/HEOR at LEO Pharma, and Assistant Director of Health Economics and Outcomes Research at Novartis. He also served as the Director of Research at Express Scripts, where he contributed to the development of cutting-edge methodologies for evaluating the clinical and economic impact of pharmaceutical interventions.
Academic Background
Dr. Kulkarni holds a Ph.D. in Health Economics and Policy from the University of Pennsylvania, where he conducted groundbreaking research on the utilization and cost-effectiveness of novel therapies. His academic achievements include numerous peer-reviewed publications, presentations at leading industry conferences, and recognition for his contributions to the field of health economics and outcomes research.
Areas of Expertise
- Health economic modeling and decision analysis
- Real-world evidence generation and synthesis
- Comparative effectiveness research and value assessment
- Strategic market access and pricing strategy development
- Cross-functional leadership and team management
- Effective communication of complex data-driven insights
Professional Impact
Throughout his career, Dr. Kulkarni has led the development and implementation of innovative health economic models that have informed the market access strategies for several high-profile pharmaceutical products. His work has contributed to the successful reimbursement and uptake of these therapies, ultimately improving patient access and health outcomes. Dr. Kulkarni is also recognized as a thought leader in the industry, frequently invited to speak at conferences and contribute to industry publications.
Conclusion
With his extensive experience, strong technical expertise, and proven track record of driving strategic initiatives, Dr. Amit Kulkarni is well-positioned to continue making significant contributions to the pharmaceutical industry. As the Head of Health Economic Modeling and Decision Sciences at Otsuka Pharmaceutical Companies (U.S.), he is dedicated to leveraging advanced analytics and data-driven insights to optimize decision-making and enhance patient care.
